{
    "body": "Which pathway is activated by ficolin-3?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18006063", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25069872", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19939495", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23142462", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24336142", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19535802", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25178935", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18261799", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21890891"
    ], 
    "ideal_answer": [
        "Ficolin-3 activates lectin complement pathway."
    ], 
    "exact_answer": [
        "lectin complement pathway"
    ], 
    "concepts": [
        "http://www.uniprot.org/uniprot/FCN3_HUMAN"
    ], 
    "type": "factoid", 
    "id": "56c1d856ef6e394741000032", 
    "snippets": [
        {
            "offsetInBeginSection": 93, 
            "offsetInEndSection": 231, 
            "text": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway and SLE. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25069872", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 179, 
            "text": "Ficolin-3 (also called H-ficolin or Hakata antigen) is a complement-activating pattern recognition molecule, possessing a fibrinogen-like domain involved in carbohydrate binding. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25178935", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 421, 
            "offsetInEndSection": 625, 
            "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA) and measured as Ficolin-3 binding and deposition of C4, C3 and the terminal complement complex (TCC).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25069872", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1458, 
            "offsetInEndSection": 1686, 
            "text": "Furthermore, Ficolin-3 mediated complement activation may be valuable in monitoring disease activity in SLE patients due to the high sensitivity for complement consumption in the assay independent of the Ficolin-3 concentration.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25069872", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 166, 
            "text": "OBJECTIVES: To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology and outcome.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336142", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1303, 
            "offsetInEndSection": 1649, 
            "text": "CONCLUSION: Our data provide evidence that LCP is activated after SAH and that the actual plasma concentrations of ficolin-3 reflect the severity of brain injury as evaluated by clinical and structural parameters. These results support the idea that ficolin-3-mediated functional LCP activity may be targeted to control injury progression in SAH.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336142", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 97, 
            "text": "Ficolin-3-mediated lectin complement pathway activation in patients with subarachnoid hemorrhage.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336142", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 168, 
            "text": "MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19939495", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 1134, 
            "offsetInEndSection": 1303, 
            "text": "Moreover, Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway initiators.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18006063", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1592, 
            "offsetInEndSection": 1794, 
            "text": "Moreover, Ficolin-3 is the primary acceptor molecule of MASP-3 among the LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19939495", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 115, 
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18261799", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 146, 
            "text": "Ficolin-3, encoded by the FCN3 gene and expressed in the lung and liver, is a recognition molecule in the lectin pathway of the complement system.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19535802", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 309, 
            "text": "Ficolin-1, -2 and -3 are recognition molecules in the lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two nonenzymatic proteins. MASP-2 is the main initiator of lectin pathway activation, while ficolin-3 is the most abundant ficolin molecule in the circulation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23142462", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 310, 
            "text": "Ficolin-3 (also called H-ficolin or Hakata antigen) is a complement-activating pattern recognition molecule, possessing a fibrinogen-like domain involved in carbohydrate binding. Amongst human ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin pathway activator in vitro.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25178935", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1554, 
            "offsetInEndSection": 1756, 
            "text": "Moreover, Ficolin-3 is the primary acceptor molecule of MASP-3 among the LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19939495", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 630, 
            "offsetInEndSection": 781, 
            "text": "Moreover, these LPS/ficolin-3 complexes activated the lectin pathway of complement in a C4b-deposition assay in a calcium- and magnesium-dependent way.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21890891", 
            "endSection": "abstract"
        }
    ]
}